Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma
- 1 October 2014
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 28 (5) , 775-790
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Screening Panels for Detection of Monoclonal GammopathiesClinical Chemistry, 2009
- Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective studyBlood, 2009
- Criteria for diagnosis, staging, risk stratification and response assessment of multiple myelomaLeukemia, 2008
- Elimination of the Need for Urine Studies in the Screening Algorithm for Monoclonal Gammopathies by Using Serum Immunofixation and Free Light Chain AssaysMayo Clinic Proceedings, 2006
- Long-term Follow-up of 241 Patients With Monoclonal Gammopathy of Undetermined Significance: The Original Mayo Clinic Series 25 Years LaterMayo Clinic Proceedings, 2004
- Serum Reference Intervals and Diagnostic Ranges for Free κ and Free λ Immunoglobulin Light Chains: Relative Sensitivity for Detection of Monoclonal Light ChainsClinical Chemistry, 2002
- A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined SignificanceNew England Journal of Medicine, 2002
- Monoclonal gammopathies in the adult population of Finistère, France.Journal of Clinical Pathology, 1982
- Monoclonal gammopathy of undetermined significanceThe American Journal of Medicine, 1978
- Frequency of Pathological Proteins (M‐components) in 6,995 Sera from an Adult PopulationActa Medica Scandinavica, 1966